SPEM (CD44v10+) and IM (MUC2+, TFF3+) are both precursor lesions associated with human gastric adenocarcinoma (Schmidt et al, 1999; Yamaguchi et al, 2002; Halldorsdottir et al, 2003). This evidence concerns the gene MUC2 and gastric adenocarcinoma.